Join
Live feed
·
INSIDERFilingvia Quantisnow
Pasithea Therapeutics Corp. logo

Director Steinman Lawrence bought $100,000 worth of shares (133,333 units at $0.75), increasing direct ownership by 201% to 199,691 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KTTA· Pasithea Therapeutics Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KTTA (Pasithea Therapeutics Corp.) and more on Quantisnow.